Brief: Interpace Diagnostics Announces Further Expansion Of Thyroid Business
Jan 22 (Reuters) - Interpace Diagnostics Group Inc IDXG.O :
* INTERPACE DIAGNOSTICS ANNOUNCES FURTHER EXPANSION OF
THYROID
BUSINESS
* INTERPACE DIAGNOSTICS - EXPANDED SERVICES TO NOW ALSO
PROCESS
SPECIMENS PREPARED IN FORMALIN FIXED, PARAFFIN-EMBEDDED (FFPE)
SAMPLES
Source text for Eikon: ID:nGNXfsT8v
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million